David Kaufman
Venture Partner at Third Rock Ventures
Boston, Massachusetts
Writes $100K – $5M checks · typically $1.5M
About
Physician-scientist who joined Third Rock Ventures as a venture partner in 2020 and became partner in 2022. He previously served as Chief Medical Officer and Head of Translational Development at the Gates Medical Research Institute and led Translational Oncology at Merck Research Laboratories.
Invests in
BiotechDigital HealthMedical Devices
Deals · 1
Abata TherapeuticsBoard seat
via Third Rock Ventures · filed Dec 2023
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Third Rock Ventures
Abbie Celniker
Investor at Third Rock Ventures
Adam Tebbe
Investor at Third Rock Ventures
Alan Ezekowitz
Investor at Third Rock Ventures
Alison Connors
Investor at Third Rock Ventures
Amanda Chan
Investor at Third Rock Ventures
Andrea van Elsas
Investor at Third Rock Ventures
Andrew Warren
Senior Associate at Third Rock Ventures
Angelo Severino
Investor at Third Rock Ventures
Network5
Abbie Celniker
Investor at Third Rock Ventures
Alan Ezekowitz
Investor at Third Rock Ventures
Andrea van Elsas
Investor at Third Rock Ventures
Andrew Warren
Senior Associate at Third Rock Ventures
Barbara Weber
Venture Partner at Third Rock Ventures
Investors connected to David in public investor directories — a warm-intro map.